<code id='37378B8C0F'></code><style id='37378B8C0F'></style>
    • <acronym id='37378B8C0F'></acronym>
      <center id='37378B8C0F'><center id='37378B8C0F'><tfoot id='37378B8C0F'></tfoot></center><abbr id='37378B8C0F'><dir id='37378B8C0F'><tfoot id='37378B8C0F'></tfoot><noframes id='37378B8C0F'>

    • <optgroup id='37378B8C0F'><strike id='37378B8C0F'><sup id='37378B8C0F'></sup></strike><code id='37378B8C0F'></code></optgroup>
        1. <b id='37378B8C0F'><label id='37378B8C0F'><select id='37378B8C0F'><dt id='37378B8C0F'><span id='37378B8C0F'></span></dt></select></label></b><u id='37378B8C0F'></u>
          <i id='37378B8C0F'><strike id='37378B8C0F'><tt id='37378B8C0F'><pre id='37378B8C0F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:94627
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          House panel takes first step toward fixing drug shortages
          House panel takes first step toward fixing drug shortages

          EnergyandCommerceChairCathyMcMorris-Rodgers(R-Wash.)AnnaMoneymaker/GettyImagesWASHINGTON—AHousesubco

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

          AdobeHospitals,pharmacies,andotherhealthcareprovidersaregettingstuckinaninsuranceprocessinglogjamaft